insights_auto
Why is GTBP down 2.11%?
Dive Deeperchevron_right
GTBP:NASDAQ
GT Biopharma Inc
$3.72
arrow_downward
-2.11%(-0.080) 1D
Nov 13, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GTBP...
Open
$3.85
High
$4.11
Low
$3.60
Mkt. cap
7.67M
Avg. vol.
62.87K
Volume
66.92K
52-wk high
$28.75
52-wk low
$3.60
EPS
-$35.41
Beta
0.88
Shares outstanding
2.06M
No. of employees
1
Open
$3.85
High
$4.11
Low
$3.60
Mkt. cap
7.67M
Avg. vol.
62.87K
Volume
66.92K
52-wk high
$28.75
52-wk low
$3.60
EPS
-$35.41
Beta
0.88
Shares outstanding
2.06M
No. of employees
1
News stories
From web sources and news partners
AP News
·
1 day ago
Microsoft outage shows the risks of relying on a single technology provider for essential services
Yahoo Finance
·
16 hours ago
SpaceX’s S&P 500 Bid Gets New Life as Musk Pitches Tesla Merger
24/7 Wall St.
·
7 hours ago
He Thinks His $200,000 S&P 500 401(k) Spreads His AI Risk. Two Alphabet Share Classes Put $10,380 in One Company. A 20% Drop Could Cost Him $2,076
Investor's Business Daily
·
1 day ago
Stock Market Falls But Nasdaq Holds Key Level; Anthropic IPO, Nvidia Earnings Loom
About GT Biopharma Inc
CEO-
Employees1
Founded1965
HeadquartersSan Francisco, California, United States
SectorHealth Care
IndustryBiotechnology
Websitegtbiopharma.com